{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:41:35Z","timestamp":1721688095624},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s12035-015-9646-8","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T22:13:32Z","timestamp":1451340812000},"page":"15-21","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Understanding Ependymoma Oncogenesis: an Update on Recent Molecular Advances and Current Perspectives"],"prefix":"10.1007","volume":"54","author":[{"given":"Kirti","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravin","family":"Salunke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,28]]},"reference":[{"issue":"4","key":"9646_CR1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3171\/2008.9.JNS08117","volume":"110","author":"CS McGuire","year":"2009","unstructured":"McGuire CS, Sainani KL, Fisher PG (2009) Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study. J Neurosurg 110(4):725\u20139","journal-title":"J Neurosurg"},{"key":"9646_CR2","volume-title":"WHO Classification of Tumours of the Central Nervous System","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO Classification of Tumours of the Central Nervous System. International Agency for Research on Cancer (IARC), Lyon"},{"issue":"4","key":"9646_CR3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ccr.2005.09.001","volume":"8","author":"MD Taylor","year":"2005","unstructured":"Taylor MD et al (2005) Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8(4):323\u201335","journal-title":"Cancer Cell"},{"issue":"2","key":"9646_CR4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97\u2013109","journal-title":"Acta Neuropathol"},{"issue":"15","key":"9646_CR5","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1200\/JCO.2004.11.142","volume":"22","author":"TE Merchant","year":"2004","unstructured":"Merchant TE et al (2004) Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 22(15):3156\u201362","journal-title":"J Clin Oncol"},{"issue":"2","key":"9646_CR6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000120364","volume":"14","author":"LE Kun","year":"1988","unstructured":"Kun LE, Kovnar EH, Sanford RA (1988) Ependymomas in children. Pediatr Neurosci 14(2):57\u201363","journal-title":"Pediatr Neurosci"},{"key":"9646_CR7","first-page":"559","volume":"44","author":"RA Sanford","year":"1997","unstructured":"Sanford RA, Gajjar A (1997) Ependymomas. Clin Neurosurg 44:559\u201370","journal-title":"Clin Neurosurg"},{"issue":"22","key":"9646_CR8","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1158\/1078-0432.CCR-14-0833","volume":"20","author":"A Gajjar","year":"2014","unstructured":"Gajjar A et al (2014) Molecular insights into pediatric brain tumors have the potential to transform therapy. Clin Cancer Res 20(22):5630\u201340","journal-title":"Clin Cancer Res"},{"issue":"3","key":"9646_CR9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1470-2045(08)70342-5","volume":"10","author":"TE Merchant","year":"2009","unstructured":"Merchant TE et al (2009) Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol 10(3):258\u201366","journal-title":"Lancet Oncol"},{"issue":"8","key":"9646_CR10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1470-2045(07)70208-5","volume":"8","author":"RG Grundy","year":"2007","unstructured":"Grundy RG et al (2007) Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG\/SIOP prospective study. Lancet Oncol 8(8):696\u2013705","journal-title":"Lancet Oncol"},{"issue":"1","key":"9646_CR11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(13)70548-5","volume":"15","author":"G Gatta","year":"2014","unstructured":"Gatta G et al (2014) Childhood cancer survival in Europe 1999\u20132007: results of EUROCARE-5\u2014a population-based study. Lancet Oncol 15(1):35\u201347","journal-title":"Lancet Oncol"},{"issue":"3","key":"9646_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11910-010-0103-9","volume":"10","author":"AM Dubuc","year":"2010","unstructured":"Dubuc AM et al (2010) The genetics of pediatric brain tumors. Curr Neurol Neurosci Rep 10(3):215\u201323","journal-title":"Curr Neurol Neurosci Rep"},{"key":"9646_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-5751-10-7","volume":"10","author":"DW Ellison","year":"2011","unstructured":"Ellison DW et al (2011) Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed 10:7","journal-title":"J Negat Results Biomed"},{"issue":"10","key":"9646_CR14","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00381-008-0804-4","volume":"25","author":"C Godfraind","year":"2009","unstructured":"Godfraind C (2009) Classification and controversies in pathology of ependymomas. Childs Nerv Syst 25(10):1185\u201393","journal-title":"Childs Nerv Syst"},{"issue":"7306","key":"9646_CR15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nature09173","volume":"466","author":"RA Johnson","year":"2010","unstructured":"Johnson RA et al (2010) Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466(7306):632\u20136","journal-title":"Nature"},{"issue":"10","key":"9646_CR16","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/cncr.11783","volume":"98","author":"M Fouladi","year":"2003","unstructured":"Fouladi M et al (2003) Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients. Cancer 98(10):2232\u201344","journal-title":"Cancer"},{"issue":"2","key":"9646_CR17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00401-012-0981-9","volume":"124","author":"C Godfraind","year":"2012","unstructured":"Godfraind C et al (2012) Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas. Acta Neuropathol 124(2):247\u201357","journal-title":"Acta Neuropathol"},{"key":"9646_CR18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1476-4598-6-47","volume":"6","author":"E Rousseau","year":"2007","unstructured":"Rousseau E et al (2007) Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma. Mol Cancer 6:47","journal-title":"Mol Cancer"},{"issue":"4","key":"9646_CR19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3171\/jns.2000.93.4.0605","volume":"93","author":"D Figarella-Branger","year":"2000","unstructured":"Figarella-Branger D et al (2000) Prognostic factors in intracranial ependymomas in children. J Neurosurg 93(4):605\u201313","journal-title":"J Neurosurg"},{"issue":"2","key":"9646_CR20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/modpathol.3800999","volume":"21","author":"T Tihan","year":"2008","unstructured":"Tihan T et al (2008) The prognostic value of histological grading of posterior fossa ependymomas in children: a Children\u2019s Oncology Group study and a review of prognostic factors. Mod Pathol 21(2):165\u201377","journal-title":"Mod Pathol"},{"issue":"10","key":"9646_CR21","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/01.MP.0000087420.34166.B6","volume":"16","author":"J Zamecnik","year":"2003","unstructured":"Zamecnik J et al (2003) Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors. Mod Pathol 16(10):980\u201391","journal-title":"Mod Pathol"},{"issue":"3\u20134","key":"9646_CR22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF01400495","volume":"111","author":"RI Ernestus","year":"1991","unstructured":"Ernestus RI, Wilcke O, Schroder R (1991) Supratentorial ependymomas in childhood: clinicopathological findings and prognosis. Acta Neurochir (Wien) 111(3\u20134):96\u2013102","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"9646_CR23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/02688699745925","volume":"11","author":"RI Ernestus","year":"1997","unstructured":"Ernestus RI et al (1997) The clinical and prognostic relevance of grading in intracranial ependymomas. Br J Neurosurg 11(5):421\u20138","journal-title":"Br J Neurosurg"},{"issue":"3","key":"9646_CR24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00043426-199905000-00008","volume":"21","author":"B Horn","year":"1999","unstructured":"Horn B et al (1999) A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Pediatr Hematol Oncol 21(3):203\u201311","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"9646_CR25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/B:NEON.0000033383.84900.c1","volume":"68","author":"TH Jaing","year":"2004","unstructured":"Jaing TH et al (2004) Multivariate analysis of clinical prognostic factors in children with intracranial ependymomas. J Neurooncol 68(3):255\u201361","journal-title":"J Neurooncol"},{"issue":"6","key":"9646_CR26","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/cncr.20075","volume":"100","author":"A Korshunov","year":"2004","unstructured":"Korshunov A et al (2004) The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients. Cancer 100(6):1230\u20137","journal-title":"Cancer"},{"issue":"2","key":"9646_CR27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jss.2009.04.024","volume":"156","author":"D Rodriguez","year":"2009","unstructured":"Rodriguez D et al (2009) Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973\u20132005). J Surg Res 156(2):340\u201351","journal-title":"J Surg Res"},{"issue":"5","key":"9646_CR28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/bpa.12050","volume":"23","author":"A Raghunathan","year":"2013","unstructured":"Raghunathan A et al (2013) Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system. Brain Pathol 23(5):584\u201394","journal-title":"Brain Pathol"},{"issue":"5","key":"9646_CR29","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0002-9440(10)63530-4","volume":"163","author":"A Korshunov","year":"2003","unstructured":"Korshunov A et al (2003) Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age. Am J Pathol 163(5):1721\u20137","journal-title":"Am J Pathol"},{"issue":"3","key":"9646_CR30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000028637","volume":"28","author":"F Sala","year":"1998","unstructured":"Sala F et al (1998) Prognostic factors in childhood intracranial ependymomas: the role of age and tumor location. Pediatr Neurosurg 28(3):135\u201342","journal-title":"Pediatr Neurosurg"},{"issue":"6","key":"9646_CR31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1158\/1541-7786.MCR-08-0584","volume":"7","author":"JP Kilday","year":"2009","unstructured":"Kilday JP et al (2009) Pediatric ependymoma: biological perspectives. Mol Cancer Res 7(6):765\u201386","journal-title":"Mol Cancer Res"},{"issue":"19","key":"9646_CR32","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2009.27.3359","volume":"28","author":"A Korshunov","year":"2010","unstructured":"Korshunov A et al (2010) Molecular staging of intracranial ependymoma in children and adults. J Clin Oncol 28(19):3182\u201390","journal-title":"J Clin Oncol"},{"issue":"6","key":"9646_CR33","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.bjc.6600180","volume":"86","author":"M Carter","year":"2002","unstructured":"Carter M et al (2002) Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer 86(6):929\u201339","journal-title":"Br J Cancer"},{"issue":"6","key":"9646_CR34","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0002-9440(10)64491-4","volume":"161","author":"S Dyer","year":"2002","unstructured":"Dyer S et al (2002) Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am J Pathol 161(6):2133\u201341","journal-title":"Am J Pathol"},{"issue":"7 Pt 1","key":"9646_CR35","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/1078-0432.CCR-05-2363","volume":"12","author":"F Mendrzyk","year":"2006","unstructured":"Mendrzyk F et al (2006) Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res 12(7 Pt 1):2070\u20139","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9646_CR36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/gcc.1167","volume":"32","author":"S Ward","year":"2001","unstructured":"Ward S et al (2001) Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma. Genes Chromosomes Cancer 32(1):59\u201366","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"9646_CR37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cancergencyto.2007.12.008","volume":"182","author":"CM Monoranu","year":"2008","unstructured":"Monoranu CM et al (2008) Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas. Cancer Genet Cytogenet 182(1):18\u201326","journal-title":"Cancer Genet Cytogenet"},{"issue":"7489","key":"9646_CR38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature13109","volume":"506","author":"M Parker","year":"2014","unstructured":"Parker M et al (2014) C11orf95-RELA fusions drive oncogenic NF-kappaB signalling in ependymoma. Nature 506(7489):451\u20135","journal-title":"Nature"},{"issue":"2","key":"9646_CR39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2011.07.007","volume":"20","author":"H Witt","year":"2011","unstructured":"Witt H et al (2011) Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20(2):143\u201357","journal-title":"Cancer Cell"},{"issue":"5","key":"9646_CR40","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00401-012-0941-4","volume":"123","author":"K Wani","year":"2012","unstructured":"Wani K et al (2012) A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol 123(5):727\u201338","journal-title":"Acta Neuropathol"},{"issue":"5","key":"9646_CR41","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","volume":"27","author":"KW Pajtler","year":"2015","unstructured":"Pajtler KW et al (2015) Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27(5):728\u201343","journal-title":"Cancer Cell"},{"issue":"27","key":"9646_CR42","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1200\/JCO.2014.59.9217","volume":"33","author":"A Gajjar","year":"2015","unstructured":"Gajjar A et al (2015) Pediatric brain tumors: innovative genomic information is transforming the diagnostic and clinical landscape. J Clin Oncol 33(27):2986\u201398","journal-title":"J Clin Oncol"},{"issue":"7489","key":"9646_CR43","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature13108","volume":"506","author":"SC Mack","year":"2014","unstructured":"Mack SC et al (2014) Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature 506(7489):445\u201350","journal-title":"Nature"},{"issue":"3","key":"9646_CR44","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0002-9440(10)64061-8","volume":"158","author":"Y Hirose","year":"2001","unstructured":"Hirose Y et al (2001) Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 158(3):1137\u201343","journal-title":"Am J Pathol"},{"issue":"1","key":"9646_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(99)00046-1","volume":"113","author":"C Mazewski","year":"1999","unstructured":"Mazewski C et al (1999) Karyotype studies in 18 ependymomas with literature review of 107 cases. Cancer Genet Cytogenet 113(1):1\u20138","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"9646_CR46","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0002-9440(10)65158-9","volume":"155","author":"C Ebert","year":"1999","unstructured":"Ebert C et al (1999) Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am J Pathol 155(2):627\u201332","journal-title":"Am J Pathol"},{"issue":"33","key":"9646_CR47","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1200\/JCO.2006.06.3701","volume":"24","author":"P Modena","year":"2006","unstructured":"Modena P et al (2006) Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 24(33):5223\u201333","journal-title":"J Clin Oncol"},{"issue":"12","key":"9646_CR48","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jmg.37.12.897","volume":"37","author":"DG Evans","year":"2000","unstructured":"Evans DG, Sainio M, Baser ME (2000) Neurofibromatosis type 2. J Med Genet 37(12):897\u2013904","journal-title":"J Med Genet"},{"issue":"1","key":"9646_CR49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00006123-199607000-00026","volume":"39","author":"BD Birch","year":"1996","unstructured":"Birch BD et al (1996) Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas. Neurosurgery 39(1):135\u201340","journal-title":"Neurosurgery"},{"issue":"1","key":"9646_CR50","first-page":"45","volume":"54","author":"MP Rubio","year":"1994","unstructured":"Rubio MP et al (1994) Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 54(1):45\u20137","journal-title":"Cancer Res"},{"issue":"4","key":"9646_CR51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.2910640406","volume":"64","author":"I Slavc","year":"1995","unstructured":"Slavc I et al (1995) Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Int J Cancer 64(4):243\u20137","journal-title":"Int J Cancer"},{"issue":"5","key":"9646_CR52","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00401-011-0904-1","volume":"123","author":"HA Rogers","year":"2012","unstructured":"Rogers HA et al (2012) Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death. Acta Neuropathol 123(5):711\u201325","journal-title":"Acta Neuropathol"},{"issue":"1","key":"9646_CR53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cancergencyto.2005.09.004","volume":"166","author":"MB Michalowski","year":"2006","unstructured":"Michalowski MB et al (2006) Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma. Cancer Genet Cytogenet 166(1):74\u201381","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"9646_CR54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2004.11.044","volume":"227","author":"DW Hamilton","year":"2005","unstructured":"Hamilton DW et al (2005) Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma. Cancer Lett 227(1):75\u201381","journal-title":"Cancer Lett"},{"issue":"2","key":"9646_CR55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0165-4608(02)00928-7","volume":"144","author":"ME Alonso","year":"2003","unstructured":"Alonso ME et al (2003) Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas. Cancer Genet Cytogenet 144(2):134\u201342","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"9646_CR56","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.0305-1846.2003.00505.x","volume":"29","author":"E Rousseau","year":"2003","unstructured":"Rousseau E et al (2003) CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours. Neuropathol Appl Neurobiol 29(6):574\u201383","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"9646_CR57","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ijc.20165","volume":"110","author":"A Waha","year":"2004","unstructured":"Waha A et al (2004) Analysis of HIC-1 methylation and transcription in human ependymomas. Int J Cancer 110(4):542\u20139","journal-title":"Int J Cancer"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9646-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9646-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9646-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9646-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:37:50Z","timestamp":1567471070000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9646-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,28]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["9646"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9646-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,28]]}}}